A carregar...
Neoadjuvant therapy for gastrointestinal stromal tumor
Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...
Na minha lista:
Publicado no: | Transl Gastroenterol Hepatol |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
AME Publishing Company
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/ https://ncbi.nlm.nih.gov/pubmed/29441368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|